# UK researchers are rushing to develop a new Ebola vaccine based on the exact same viral vector platform used in the Oxford/AstraZeneca COVID-19 jab.

*biotech · news · 2026-05-24 · The Gateway Pundit*

## Key points

- The Oxford Vaccine Group is fast-tracking a Bundibugyo Ebolavirus vaccine using the ChAdOx1 platform.
- No approved vaccines currently exist for the Bundibugyo strain, unlike the Zaire strain of Ebola.
- Human clinical trials for ChAdOx1 BDBV could begin in two to three months if animal tests succeed.
- The ChAdOx1 platform's flexibility enables rapid adaptation to target emerging pathogens like new Ebola strains.
- Vaccines from the same Oxford team were selected by WHO for outbreak trials in Uganda and beyond.

**Companies:** AstraZeneca, Oxford Vaccine Group
**Countries:** UK, Democratic Republic of Congo

[Read the full story on The Gateway Pundit](https://www.thegatewaypundit.com/2026/05/uk-scientists-rushing-create-ebola-vaccine-using-covid/)

---

Canonical: https://newsio.io/n/5cee29e9-5a40-4e61-9220-c14832ca1acf/uk-researchers-are-rushing-to-develop-a-new-ebola-vaccine-based-on-the-exact-sam
Summarized by Newsio from The Gateway Pundit. https://newsio.io/how-it-works